HOW TO GET
NERLYNX
SUPPORT CO-PAY
CARD
REQUEST
CONTACT

This site is intended for healthcare professionals.
Prescribing Information For patients, click here.

MENU

Supporting Your Patients as They Take Their
Next Step With Extended Adjuvant Therapy

Access and Reimbursement Support

For patients prescribed with NERLYNX tablets, Puma Patient Lynx provides the following support services:

Magnifying glass icon

Benefits Verification and Prior Authorization Support
Our reimbursement counselors will conduct a benefits investigation, verify insurance approval or coverage, and obtain and submit necessary documentation for patients requiring prior authorization.

Dollar sign icon

Financial Support
For patients with financial needs, we will work to find appropriate sources for support.

Checklist icon

Co-Pay Assistance
Commercially insured, eligible patients treated with NERLYNX™ (neratinib) tablets may pay as little as $10 per prescription.* Patients will be enrolled through their specialty pharmacy.

Pointing finger icon

NERLYNX Quick Start
Provides a free 3-week supply of NERLYNX to eligible patients experiencing delays in gaining access to therapy.

Ongoing Treatment Support

For patients currently taking NERLYNX, Puma Patient Lynx provides the following services:

Product support icon

Product Support
Our specialty pharmacy network will provide patients with product education and side-effect counseling to help them better understand and manage their NERLYNX therapy.

Envelope icon

Text Message Support Program
Patients can sign up to receive medication reminders and motivational messages to support treatment adherence.

For more information on the Puma Patient Lynx Support Program:
1-855-816-5421, Monday—Friday, 9 AM—8 PM ET

*Limitations apply. Patient must have commercial insurance. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Puma Biotechnology reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, call 1-855-816-5421.

Prescribing Information

From the indication to clinical studies, read through the Prescribing Information.

View PDF »

Patient co-pay card

See how we assist patients with their NERLYNX prescription.

Learn More »

REQUEST CONTACT

Request to be contacted by a NERLYNX sales representative or a Clinical Nurse Educator (CNE)

Go »

IMPORTANT SAFETY INFORMATION

NERLYNX (neratinib) tablets, for oral use

INDICATIONS AND USAGE: NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.

CONTRAINDICATIONS: None

WARNINGS AND PRECAUTIONS:

ADVERSE REACTIONS: The most common adverse reactions (≥ 5%) were diarrhea, nausea, abdominal pain, fatigue, vomiting, rash, stomatitis, decreased appetite, muscle spasms, dyspepsia, AST or ALT increase, nail disorder, dry skin, abdominal distention, epistaxis, weight decreased and urinary tract infection.

To report SUSPECTED ADVERSE REACTIONS, contact Puma Biotechnology, Inc. at 1-844-NERLYNX (1-844-637-5969) and www.NERLYNX.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS:

USE IN SPECIFIC POPULATIONS:

For Full Prescribing Information, please click here.